Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy: A systematic review and network meta‐analysis of randomized controlled trials

Published:2022-01-08 Issue: Volume: Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metabolism Res

Author:

Zheng Hui¹²^ORCID,Sigal Ronald J.³,Coyle Doug¹,Bai Zemin⁴,Johnston Amy⁴^ORCID,Elliott Jesse⁴,Hsieh Shuching⁴,Kelly Shannon E.¹⁴,Chen Li⁴,Skidmore Becky⁵,Toupin‐April Karine¹⁶⁷⁸,Wells George A.¹⁴

Affiliation:

1. School of Epidemiology and Public Health, University of Ottawa Ottawa Ontario Canada

2. Centre for Food‐borne, Environment and Zoonotic Infectious Disease, Public Health Agency of Canada Ottawa Ontario Canada

3. Division of Endocrinology and Metabolism, Departments of Medicine, Cardiac Sciences and Community Health Sciences University of Calgary Calgary Alberta Canada

4. Cardiovascular Research Methods Centre, University of Ottawa Heart Institute Ottawa Ontario Canada

5. Independent Information Specialist Ottawa Ontario Canada

6. Children's Hospital of Eastern Ontario Research Institute Ottawa Ontario Canada

7. Department of Pediatrics, Faculty of Medicine University of Ottawa Ottawa Ontario Canada

8. School of Rehabilitation Sciences, Faculty of Health Sciences University of Ottawa Ottawa Ontario Canada

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3515

Reference49 articles.

1. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus;Diabetes Control and Complications Trial Research Group;N Engl J Med,1993

2. Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;lancet,1998

3. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC‐Norfolk);Wareham KT;BMJ,2001

4. Management of hyperglycemia in type 2 diabetes, 2015: a patient‐centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi SE;Diabetes Care,2015

5. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm–2018 executive summary;Garber AJ;Endocr Pract,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease;Current Pharmaceutical Design;2023-09-06

2. Efficacy of Regimens in the Treatment of Latent Autoimmune Diabetes in Adults: A Network Meta-analysis;Diabetes Therapy;2023-08-16

3. Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication;Biomedicine & Pharmacotherapy;2022-12

4. Adult-onset autoimmune diabetes;Nature Reviews Disease Primers;2022-09-22

5. The risk of incident atrial fibrillation in patients with type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors: a nationwide cohort study;Cardiovascular Diabetology;2022-06-28